Article
Four things worth weighing — two that count in its favour, two that do not.
In its favour
The amounts are published. Every ingredient carries a milligram figure on the Supplement Facts panel. In a category built on hiding doses inside proprietary blends, that is unusual and it deserves credit.
The claims are handled carefully. The marketing does not present this as a dementia or Alzheimer’s treatment, and it flags the blood-pressure interaction rather than burying it. Plenty of competitors do neither.
Against it
The amounts are modest. 200 mg of arginine is well below what most circulation research uses. Publishing a figure is good; the figure still has to be judged, and this is a convenience dose rather than a clinical one.
No trial of the finished formula. The individual ingredients have research behind them. The product does not, as far as we could establish — which is normal for the category and still worth knowing.
Verdict
Reasonable to try if you are not on blood-flow medication, your expectations sit at support rather than transformation, and you treat the 60-day promise as the real safety net.
And the line that matters most. MemoHoney is a dietary supplement, not a medical treatment. It does not diagnose, treat, cure or prevent dementia, Alzheimer’s disease or any other diagnosed cognitive disorder. Memory changes that worry you belong with a doctor, and nothing on this site is a reason to put that off.
Order today
The 6-bottle package brings it to $49 a bottle, ships free across the US and saves you $780 against the regular price.
Backed by a 60-day money-back guarantee · no subscription
From $49 a bottleSave up to $780 · 60-day guarantee
Buy now